Helicobacter pylori Lipopolysaccharide Upregulates MDM2 via the TLR4/MAPK/AP-1 Pathway to Promote Gastric Cancer
Yuqin Li1, Lin Xu2, Xiaolan Lu1
1Department of Gastroenterology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Background:
The lipopolysaccharide (LPS) of Helicobacter pylori (HP) is a critical virulence factor in gastric cancer development. As a toxic component of the HP cytoderm, HP LPS causes persistent inflammatory injury to the gastric mucosa. Although HP lipopolysaccharide exhibits weaker endotoxic activity, it still promotes gastric cancer progression by inducing chronic inflammation and enhancing cellular proliferation. However, the specific signaling pathways involved are not fully understood.
Methods:
GES-1, HGC-27, and MKN-45 cells were treated with LPS from HP and E. coli. Western blotting and a luciferase reporter assay were used to analyze MDM2 expression and transcriptional activity. Cell proliferation, migration, and invasion were evaluated through colony formation, scratch wound healing, and transwell assays. Immunohistochemistry was used to examine MDM2 and p53 expression, while immunofluorescence detected regulatory T cells. Gastric cancer mouse models were also used to confirm MDM2's role in gastric cancer.
Results:
HP infection resulted in elevated MDM2 levels in gastric precancerous lesions and cancers. HP LPS enhances MDM2 expression in GC cells. This effect is mediated through TLR4/MAPK/AP-1, which promotes the proliferation and invasion of gastric cancer cells. In addition, MDM2 participated in Tregs infiltration and promoted the maintenance of an immunosuppressive tumor microenvironment in gastric cancer.
Conclusions:
HP LPS enhances MDM2 expression in GC cells through the TLR4/MAPK/AP-1 pathway. MDM2 mediates the protumor effects of HP LPS by promoting tumor cell proliferation and regulating Treg-mediated immune suppression. Our study deepens the understanding of gastric cancer progression and identifies MDM2 as an effective therapeutic target.
Insights
Helicobacter pylori (HP) lipopolysaccharide (LPS) boosts gastric cancer by increasing MDM2 expression via the TLR4/MAPK/AP-1 pathway, promoting cell growth and immune suppression. MDM2 is a potential therapeutic target for HP-associated gastric cancer.
Area of Science:
- Oncology
- Immunology
- Microbiology
Background:
- Helicobacter pylori (HP) lipopolysaccharide (LPS) is a key factor in gastric cancer development, causing chronic inflammation and promoting cell proliferation.
- While HP LPS has lower endotoxic activity than E. coli LPS, it significantly contributes to gastric cancer progression through unknown pathways.
Purpose of the Study:
- To elucidate the specific signaling pathways involved in HP LPS-induced gastric cancer progression.
- To investigate the role of MDM2 in HP LPS-mediated gastric tumorigenesis and immune modulation.
Main Methods:
- Cell lines (GES-1, HGC-27, MKN-45) were treated with HP and E. coli LPS.
- Western blotting and luciferase assays assessed MDM2 expression and activity.
- Cell proliferation, migration, invasion, and regulatory T cell (Treg) infiltration were evaluated.
- In vivo gastric cancer mouse models were utilized.
Main Results:
- HP infection and HP LPS increased MDM2 levels in gastric precancerous lesions and cancers.
- HP LPS upregulated MDM2 expression in gastric cancer cells via the TLR4/MAPK/AP-1 pathway.
- MDM2 promoted gastric cancer cell proliferation, invasion, and Treg-mediated immunosuppression.
Conclusions:
- HP LPS enhances MDM2 expression through the TLR4/MAPK/AP-1 signaling cascade.
- MDM2 plays a crucial role in mediating HP LPS's protumor effects, including proliferation and immune evasion.
- MDM2 represents a promising therapeutic target for managing HP-associated gastric cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
MAPK Signaling Cascades


